Article info

Download PDFPDF

Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab
Free

Authors

  1. Correspondence to Dr Joana Vasconcelos; joanapfvasconcelos{at}hotmail.com
View Full Text

Citation

Vasconcelos J, Portugal R, Torres R, et al
Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab

Publication history

  • Accepted June 3, 2021
  • First published June 28, 2021.
Online issue publication 
June 28, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.